These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38381030)

  • 21. Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study.
    Belcaro G; Dugall M; Hosoi M; Feragalli B; Cotellese R; Saggino A; Cesarone MR; Ippolito E; Cornelli U; Ledda A; Cox DB
    J Neurosurg Sci; 2024 Feb; 68(1):109-116. PubMed ID: 38299491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FlexiQule (Boswellia extract) in the supplementary management of osteoarthritis: a supplement registry.
    Belcaro G; Dugall M; Luzzi R; Ledda A; Pellegrini L; Cesarone MR; Hosoi M; Errichi M; Francis S; Cornelli U
    Minerva Med; 2014 Dec; 105(6 Suppl 2):9-16. PubMed ID: 26076376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study.
    Jessberger S; Högger P; Genest F; Salter DM; Seefried L
    BMC Complement Altern Med; 2017 Dec; 17(1):537. PubMed ID: 29246219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postpartum stretchmarks: repairing activity of an oral Centella asiatica supplementation (Centellicum®).
    Hu S; Belcaro G; Hosoi M; Feragalli B; Luzzi R; Dugall M
    Minerva Ginecol; 2018 Oct; 70(5):629-634. PubMed ID: 30293400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.
    Cotellese R; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Hosoi M; Ippolito E; Corsi M; Luzzi R
    Panminerva Med; 2021 Sep; 63(3):343-348. PubMed ID: 34738775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.
    Cesarone MR; Belcaro G; Hosoi M; Ledda A; Feragalli B; Maione C; Scipione C; Scipione V; Cotellese R; Hu S
    J Neurosurg Sci; 2020 Jun; 64(3):258-262. PubMed ID: 31957998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.
    Belcaro G; Dugall M; Bradford HD; Cesarone MR; Feragalli B; Gizzi C; Cotellese R; Hu S; Rodriguez P; Hosoi M
    Minerva Cardioangiol; 2019 Apr; 67(2):109-114. PubMed ID: 30964246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.
    Feragalli B; Dugall M; Luzzi R; Ledda A; Hosoi M; Belcaro G; Cesarone MR
    Minerva Endocrinol; 2019 Mar; 44(1):97-101. PubMed ID: 30561176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pycnogenol® prevents skin hyperpigmentation following sclerotherapy.
    Cesarone MR; Belcaro G; Cox D; Scipione V; Scipione C; Dugall M; Cornelli U; Hosoi M; Feragalli B; Hu S; Cotellese R
    Minerva Surg; 2024 Apr; 79(2):161-165. PubMed ID: 38592434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry.
    Belcaro G; Dugall M; Luzzi R; Hosoi M; Ledda A; Feragalli B; Hu S; Ganguly A; Eggenhoffner R; Corti A; Giacomelli L
    Minerva Med; 2018 Apr; 109(2):88-94. PubMed ID: 29534559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xerostomia and prevention of dryness with a Pycnogenol® mouth spray: a pilot study.
    Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Cotellese R
    Minerva Gastroenterol (Torino); 2024 Mar; 70(1):36-41. PubMed ID: 37162467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behçet syndrome: effects of Pycnogenol® supplementation during regression phases.
    Hu S; Belcaro G; Ledda A; Corsi M; Cotellese R; Feragalli B; Hosoi M; Dugall M; Torino-Rodriguez P; Cesarone MR
    Minerva Cardioangiol; 2018 Aug; 66(4):386-390. PubMed ID: 29975020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
    Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives.
    Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V
    Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation.
    Belcaro G; Cornelli U
    Int J Angiol; 2017 Jun; 26(2):95-101. PubMed ID: 28566935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®.
    Cesarone MR; Belcaro G; Agus GB; Ippolito E; Dugall M; Hosoi M; Corsi M; Cotellese R; Feragalli B; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2019 Aug; 67(4):280-287. PubMed ID: 31347820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.
    Ledda A; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hosoi M; Ippolito E; Corsi M; Luzzi R
    Evid Based Complement Alternat Med; 2021; 2021():9976299. PubMed ID: 34257695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.